Nuvation Bio Inc. 8-K

What Happened
Nuvation Bio Inc. (NASDAQ: NUVB) filed a Form 8-K on March 2, 2026 furnishing a press release that announces the company's financial results for the quarter ended December 31, 2025. The press release is attached to the 8-K as Exhibit 99.1. The company states the information in the 8-K and Exhibit 99.1 is furnished (not “filed”) and therefore not subject to certain Exchange Act filing liabilities or incorporation by reference unless explicitly stated.

Key Details

• Filing date: March 2, 2026.
• Period covered: quarter ended December 31, 2025.
• Exhibit: 99.1 — Press release announcing quarterly financial results.
• The 8-K notes the release is furnished, not filed, under Section 18 of the Exchange Act.

Why It Matters
This 8-K signals that Nuvation Bio has released its latest quarterly results (earnings, revenue and other financial metrics) to investors. Because the press release is furnished as Exhibit 99.1, investors should review that press release for the actual financial figures and operational commentary. The filing itself is a routine disclosure step that makes the company’s quarterly results publicly available; it does not, by itself, change company operations or management. Keywords: earnings, revenue, quarterly results, press release.